Ovarian cancer screening in the general population.
Détails
ID Serval
serval:BIB_B8929B155D1F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Ovarian cancer screening in the general population.
Périodique
Hormone molecular biology and clinical investigation
ISSN
1868-1891 (Electronic)
ISSN-L
1868-1883
Statut éditorial
Publié
Date de publication
06/11/2019
Peer-reviewed
Oui
Volume
41
Numéro
3
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: epublish
Publication Status: epublish
Résumé
Background Ovarian carcinoma is a poor prognosis cancer mainly due to its late diagnosis. Its incidence is relatively low but mortality is high. The symptomatology is only slightly specific, which complicates diagnostic management. It would therefore be interesting to be able to establish a diagnosis as early as possible in order to improve the prognosis of patients suffering from ovarian cancer. Materials and methods Currently, the combination of an ultrasound examination with a cancer antigen (CA)-125 assay is the most effective diagnostic technique, but not already admitted as a screening method. Therefore, we realized an exhaustive analysis of the most important studies in the last 15 years, in order to find new approaches in ovarian cancer screening. Results The age for initiating screening and its frequency are issues that are not fully resolved. The false positives and morbidity that result from screening are currently notable limitations. Conclusions The latest data do not support effective screening in the general population.
Mots-clé
CA-125 Antigen/blood, Carcinoma/blood, Carcinoma/diagnostic imaging, Carcinoma/epidemiology, Early Detection of Cancer/standards, Early Detection of Cancer/statistics & numerical data, False Positive Reactions, Female, Humans, Membrane Proteins/blood, Ovarian Neoplasms/blood, Ovarian Neoplasms/diagnostic imaging, Ovarian Neoplasms/epidemiology, Practice Guidelines as Topic, Ultrasonography/methods, Ultrasonography/standards, CA-125, detection, general population, ovarian cancer, screening
Pubmed
Web of science
Création de la notice
20/10/2020 8:25
Dernière modification de la notice
23/04/2024 6:01